Familial risk of lung cancer among nonsmokers and their relatives

American Journal of Epidemiology

Volumn 144, Issue 6, 1996, Pages 554-562

  Schwartz, Ann G ^a   Yang, Ping ^b   Swanson, G Marie ^c  

^a ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

family health; genetics; lung diseases; lung neoplasms; risk

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; RELATIVE; RISK FACTOR; UNITED STATES;

EID: 0029812731     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008965     Document Type: Article

References (59)

1. Ries LAG, Miller BA, Hankey BF, et al, eds. SEER cancer statistics review, 1973-1991: tables and graphs, National Cancer Institute. Bethesda, MD: US GPO, 1994. (National Institutes of Health (NIH) publication no. 94-2789).
2. Doll R, Hill AB. A study of the aetiology of carcinoma of the lung. Br Med J 1952;2:1271-86.
3. American Cancer Society. Cancer facts and figures - 1994. Atlanta, GA: American Cancer Society, 1994.
4. Blot WJ, Fraumeni JF. Passive smoking and lung cancer. J Natl Cancer Inst 1986;77:993-1000.
5. Fontham ETH, Correa P, Wu-Williams A, et al. Lung cancer in nonsmoking women: a multicenter case-control study. Cancer Epidemiol Biomark Prevent 1991;1:33-43.
6. Saracci R, Riboli E. Passive smoking and lung cancer: current evidence and ongoing studies at the International Agency for Research on Cancer. Mutation Res 1989;222:117-27.
7. Brownson RC, Alavanja MCR, Hock ET, et al. Passive smoking and lung cancer in nonsmoking women. Am J Public Health 1992;82:1525-30.
8. US Environmental Protection Agency. Respiratory health effects of passive smoking: lung cancer and other disorders. Washington, DC: US Environmental Protection Agency, 1992. (Environmental Protection Agency publication no. EPA/600/6-90/006F).
9. Swanson GM. Cancer prevention in the workplace and natural environment: a review of etiology, research design, and methods of risk reduction. Cancer 1988;62(suppl):1725-46.
10. Fraumeni JF, Blot WJ. Lung and pleura. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. Philadelphia, PA: WB Saunders Co., 1982.
11. Brownson RC, Alavanja MCR, Chang JC. Occupational risk factors for lung cancer among nonsmoking women: a case-control study in Missouri (United States). Cancer Causes Control 1993;4:449-54.
12. Alavanja MCR, Brownson RC, Boice JD Jr, et al. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 1992;136:623-32.
13. Van Der Wal AM, Huizinga E, Orie NGM, et al. Cancer and chronic non-specific lung disease. Scand J Respir Dis 1966; 47:161-72.
14. Cohen BH, Graves CG, Levy DA, et al. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet 1977;2:523-6.
15. Cohen BH. Chronic obstructive pulmonary disease: a challenge in genetic epidemiology. Am J Epidemiol 1980;112: 274-88.
16. Khoury MJ, Beaty TH, Newill CA, et al. Genetic-environmental interactions in chronic airways obstruction. Int J Epidemiol 1986;15:65-71.
17. Nomura A, Stemmermann GN, Chyou P-H, et al. Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis 1991;144:307-11.
18. Wu AH, Fontham ETH, Reynolds P, et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 1995;141: 1023-32.
19. Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 1963;30:289-312.
20. Sellers TA, Bailey-Wilson JE, Elston RC, et al. Evidence for mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 1990;82:1272-9.
21. Lynch HT, Kimberling WJ, Markvicka SE, et al. Genetics and smoking-associated cancers. Cancer 1986;57:1640-6.
22. Wu AH, Yu MC, Thomas DC, et al. Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res 1988;48:7279-84.
23. Osann KE. Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res 1991;51:4893-7.
24. Shaw GL, Falk RT, Pickle LW, et al. Lung cancer risk associated with cancer in relatives. J Clin Epidemiol 1991;44: 429-37.
25. Sellers TA, Potter JD, Folsom AR. Association of incident lung cancer with family history of female reproductive cancers: the Iowa Women's Health Study. Genet Epidemiol 1991;8:199-208.
26. Ooi WL, Elston RC, Chen VW, et al. Increased familial risk for lung cancer. J Natl Cancer Inst 1986;76:217-22.
27. Sellers TA, Elston RC, Atwood LD, et al. Lung cancer histologic type and family history of cancer. Cancer 1992;69: 86-91.
28. Sellers TA, Ooi WL, Elston RC, et al. Increased familial risk for non-lung cancer among relatives of lung cancer patients. Am J Epidemiol 1987;126:237-46.
29. Swanson GM, Schwartz AG, Brown KL. Population-based occupational cancer incidence surveillance. J Occup Med 1985;27:439-44.
30. Illis WR, Swanson GM, Satariano ER, et al. Summary measures of occupational history: a comparison of latest occupation and industry with usual occupation and industry. Am J Public Health 1987;77:1532-4.
31. SAS Institute, Inc. SAS technical report P-200, SAS/STAT software: CALIS and LOGISTIC procedures, release 6.04. Cary, NC: SAS Institute, Inc., 1990.
32. US Bureau of Census. Alphabetic index of industries and occupations, 1980. Washington, DC: GPO, 1981.
33. McDuffie HH. Clustering of cancer in families of patients with primary lung cancer. J Clin Epidemiol 1991;44:169-76.
34. Khoury MJ, Flanders WD. Bias in using family history as a risk factor in case-control studies of disease. Epidemiology 1995;6:511-19.
35. Sellers TA, Bailey-Wilson JE, Potter JD, et al. Effect of cohort differences in smoking prevalence on models of lung cancer susceptibility. Genet Epidemiol 1992;9:261-71.
36. Schwartz AG, Yang P, Swanson GM. Complex segregation analysis of 259 families of non-smoking lung cancer probands. (Abstract). Am J Hum Genet 1993;53:A858.
37. Kawajiri K, Natachi K, Luai K, et al. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett 1990; 263:131-3.
38. Uematsu F, Kikuchi H, Motomiya M, et al. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res 1991:82:254-6.
39. Seidegard J, Pero RW, Markowitz MM, et al. Isoenzymes of glutathione transferase (class mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis 1990;11:33-6.
40. Nazar-Stewart V, Motulsky AG, Eaton DL, et al. The glutathione S-transferase μ polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 1993;53:2313-18.
41. Kawajiri K, Wantanabe J, Eguchi H, et al. Genetic polymorphism of the drug-metabolizing enzymes and lung cancer susceptibility. Pharmacogenetics 1995;5:S70-3.
42. Sugimura H, Hamada GS, Suzuki I, et al. CYP1A1 and CYP2E1 polymorphisms and lung cancer, case-control study in Rio de Janeiro, Brazil. Pharmacogenetics 1995;5:S145-8.
43. Hirvonen A, Husgafvel-Pursianinen K, Anttila S, et al. Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer. Pharmacogenetics 1992;2: 259-63.
44. Caporaso N, DeBaum MR, Rothman N. Lung cancer and CYP2D6 (the debrisoquine polymorphism): sources of heterogeneity in the proposed association. Pharmacogenetics 1995; 5:S129-34.
45. Alexandrie A-K, Sundberg MI, Seidegard J, et al. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 1994;15:1785-90.
46. Nakachi K, Imai K, Hayashi S, et al. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991;51:5177-80.
47. Vineis P, Martone T. Genetic-environmental interactions and low-level exposure to carcinogens. Epidemiology 1995;6: 455-7.
48. Hsu TC, Johnston DA, Cherry LM, et al. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 1989;43:403-9.
49. Spitz MR, Hsu TC, Wu X, et al. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prevent 1995;4:99-103.
50. Ryberg D, Lindstedt BA, Zienolddiny S, et al. A hereditary genetic marker closely associated with microsatellite instability in lung cancer. Cancer Res 1995;55:3996-9.
51. Carey V, Zeger SL, Diggle P. Modelling multivariate binary data with alternating logistic regressions. Biometrika 1993;80: 517-26.
52. Pickle LW, Brown LM, Blot WJ. Information available from surrogate respondents in case-control interview studies. Am J Epidemiol 1983;118:99-108.
53. Bondy ML, Strom SS, Colopy MW, et al. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol 1994;47: 89-96.
54. Love RR, Evans AM, Josten DM. The accuracy of patient reports of a family history of cancer. J Chronic Dis 1985;38: 289-93.
55. Tepper A, Connally LB, Haltmeier P, et al. Knowledge of medical history information among proxy respondents for deceased study subjects. J Clin Epidemiol 1993;46: 1243-8.
56. Herrmann N. Retrospective information from questionnaires. I. Comparability of primary respondents and their next-of-kin. Am J Epidemiol 1985;121:937-47.
57. Lerchen ML, Samet JM. An assessment of the validity of questionnaire responses provided by a surviving spouse. Am J Epidemiol 1986;123:481-9.
58. McLaughlin JK, Dietz MS, Mehl ES, et al. Reliability of surrogate information on cigarette smoking by type of informant. Am J Epidemiol 1987;126:144-6.
59. McLaughlin JK, Mandel JS, Mehl ES, et al. Comparison of next-of-kin with self-respondents regarding questions on cigarette, coffee, and alcohol consumption. Epidemiology 1990; 1:408-12.